Literature DB >> 15753742

Characteristics and outcomes of cancer patients requiring mechanical ventilatory support for >24 hrs.

Márcio Soares1, Jorge I F Salluh, Nelson Spector, José R Rocco.   

Abstract

OBJECTIVES: To describe the characteristics of a large cohort of cancer patients receiving mechanical ventilation for >24 hrs and to identify clinical features predictive of in-hospital death.
DESIGN: Prospective cohort study.
SETTING: Ten-bed oncologic medical-surgical intensive care unit. PATIENTS: A total of 463 consecutive patients were included over a 45-month period.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Data were collected on the day of admission to the intensive care unit. The intensive care unit and hospital mortality rates were 50% and 64%, respectively. There were 359 (78%) patients with solid tumors and 104 (22%) with hematologic malignancies; 35 (8%) patients had leukopenia. Sepsis (63%), coma (15%), invasion or compression by tumor (11%), pulmonary embolism (7%), and cardiopulmonary arrest (6%) were the main reasons for mechanical ventilation. The independent unfavorable risk factors for mortality were older age (odds ratio, 3.09; 95% confidence interval, 1.61-5.93, for patients 40-70 yrs old, and odds ratio, 9.26; 95% confidence interval, 4.16-20.58, for patients >70 yrs old); performance status 3-4 (odds ratio, 2.51; 95% confidence interval, 1.40-4.51); cancer recurrence/progression (odds ratio, 3.43; 95% confidence interval, 1.81-6.53); Pao2/Fio2 ratio <150 (odds ratio, 2.64; 95% confidence interval, 1.40-4.99); Sequential Organ Failure Assessment score (excluding respiratory domain, each 4 points; odds ratio, 2.34; 95% confidence interval, 1.70-3.24); and airway/pulmonary invasion or compression by tumor as a reason for mechanical ventilation (odds ratio, 5.73; 95% confidence interval, 1.92-17.08).
CONCLUSIONS: Severity of acute organ failures, poor performance status, cancer status, and older age were the main determinants of mortality. The appropriate use of such easily available clinical characteristics may avoid forgoing intensive care for patients with a chance of survival.

Entities:  

Mesh:

Year:  2005        PMID: 15753742     DOI: 10.1097/01.ccm.0000155783.46747.04

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  41 in total

1.  Opening the doors of the intensive care unit to cancer patients: A current perspective.

Authors:  Silvio A Ñamendys-Silva; Erika P Plata-Menchaca; Eduardo Rivero-Sigarroa; Angel Herrera-Gómez
Journal:  World J Crit Care Med       Date:  2015-08-04

2.  Oxygen saturation/fraction of inspired oxygen ratio is a simple predictor of noninvasive positive pressure ventilation failure in critically ill patients.

Authors:  Carol Spada; Rikesh Gandhi; Sanjay R Patel; Paul Nuccio; Gerald L Weinhouse; Po-Shun Lee
Journal:  J Crit Care       Date:  2010-10-30       Impact factor: 3.425

Review 3.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

4.  Critical care management of lung cancer patients to prolong life without prolonging dying.

Authors:  Márcio Soares; Elie Azoulay
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

5.  Open the doors of the ICU to patients with malignancies and neurological complications.

Authors:  Michael Piagnerelli; Benjamin Legros
Journal:  Intensive Care Med       Date:  2009-11-12       Impact factor: 17.440

6.  Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit.

Authors:  Dominique D Benoit; Pieter O Depuydt; Koenraad H Vandewoude; Fritz C Offner; Tom Boterberg; Carole A De Cock; Lucien A Noens; Ann M Janssens; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-11-25       Impact factor: 17.440

7.  Who should be admitted to the intensive care unit? The outcome of intensive care unit admission in stage IIIB-IV lung cancer patients.

Authors:  Yu Jung Kim; Mi-Jung Kim; Young-Jae Cho; Jong Sun Park; Jin Won Kim; Hyun Chang; Jeong-Ok Lee; Keun-Wook Lee; Jee Hyun Kim; Ho Il Yoon; Soo-Mee Bang; Jae Ho Lee; Choon-Taek Lee; Jong Seok Lee
Journal:  Med Oncol       Date:  2014-01-22       Impact factor: 3.064

8.  Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.

Authors:  S G Oeyen; D D Benoit; L Annemans; P O Depuydt; S J Van Belle; R I Troisi; L A Noens; P Pattyn; J M Decruyenaere
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

9.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

10.  Antiphospholipid antibodies and multiple organ failure in critically ill cancer patients.

Authors:  Jorge I F Salluh; Márcio Soares; Ernesto De Meis
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.